Skip Nav Destination
1-8 of 8
Keywords: Kawasaki diseaseClose
Cardiology (2023) 148 (5): 457–468.
Published Online: 23 May 2023
...Jie Liu; Danyan Su; Piaoliu Yuan; Bingbing Ye; Suyuan Qin; Yusheng Pang Introduction: Multiple scoring systems for predicting intravenous immunoglobulin (IVIG) resistance have been developed. Although low-scoring patients with Kawasaki disease (KD) have a favorable prognosis, many develop coronary...
Cardiology (2018) 141 (1): 25–31.
Published Online: 10 October 2018
...Ling Sun; Yunjia Tang; Ye Wang; Guanghui Qian; Wenhua Yan; Bo Wang; Xuan Li; Haitao Lv Objectives: The purpose of the present study was to explore the changes in epidemiological, clinical and laboratory characteristics of Kawasaki disease (KD) over a 12-year period in this area. Methods...
Cardiology (2015) 130 (3): 164–165.
Published Online: 07 February 2015
...Rohit S. Loomba firstname.lastname@example.org Coronary ectasia Kawasaki disease © 2012 S. Karger AG, Basel 2015 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any...
Cardiology (2014) 129 (1): 55–64.
Published Online: 12 August 2014
...Danyan Su; Kai Wang; Suyuan Qin; Yusheng Pang Objective: To compare the safety and efficacy of warfarin plus aspirin versus aspirin alone for the treatment of children with giant coronary artery aneurysm (CAA) secondary to Kawasaki disease (KD). Methods: We searched the PubMed, EMBASE, Cochrane...
Cardiology (1995) 86 (3): 207–210.
Published Online: 19 November 2008
...Noboru Takahashi; Junichiro Fukushige; Takayuki Hijii; Hisaji Igarashi; Akio Ooshima; Kohji Veda Among the 302 children with Kawasaki disease (KD) who were evaluated by angiography from 1973 through 1992, 9 (3.0%) had either an occlusion (OC) or segmental stenosis (SS) of the right coronary artery...
Cardiology (2003) 99 (3): 121–125.
Published Online: 27 June 2003
...Monesha Gupta-Malhotra; Daniel M. Levine; Rubin S. Cooper; John B. Zabriskie Elevation of tissue-destructive proteases has been reported in acute Kawasaki disease. Cystatin C is a naturally occurring inhibitor of elastolytic cysteine protease in humans. Serum cystatin C deficiency in human beings...
Cardiology (2002) 97 (4): 180–182.
Published Online: 19 July 2002
...Monesha Gupta; Rosemary Johann-Liang; James B. Bussel; Welton M. Gersony; Thomas J.A. Lehman There is marked activation of the endothelium and immune system in Kawasaki disease. Anticardiolipin antibodies (aCL) can cause activation of the endothelium. We measured aCL levels in acute Kawasaki...
Cardiology (2000) 94 (1): 52–57.
Published Online: 22 November 2000
...Masao Nakagawa; Noriko Watanabe; Masahiko Okuno; Nobuhiko Okamoto; Hidetoshi Fujino We retrospectively studied 3 patients with Kawasaki disease (KD) and acute myocardial infarction (AMI) who were treated with intracoronary administration of tissue-type plasminogen activator (t-PA). Two-dimensional...